# CorMedix Inc.

Type: Company (CRMD)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/cormedix-inc
Canonical HTML page: https://getfinancebrief.com/entity/cormedix-inc

## Timeline

- **2026-03-06**: Earnings Calls — Management teams for both companies host conference calls to provide strategic updates and 2026 outlook.
- **2026-03-06**: Transcript Release — Full transcripts of the Q4 2025 earnings calls are made available to the public and analysts.
- **2026-03-05**: SEC Filings — Both ACFN and CRMD file 8-K reports detailing Q4 and full-year 2025 financial results.

## Recent coverage (1 stories)

### Micro-Cap Execution: Acorn Energy and CorMedix Deliver Q4 2025 Results
2026-03-06 14:25:44 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Acorn Energy and CorMedix both reported Q4 2025 financial results on March 5, 2026, marking a critical transition from development to commercial scaling. While Acorn focuses on high-margin IoT recurring revenue, CorMedix is navigating the complex rollout of its lead product, DefenCath, in the dialysis market.
Full story: https://getfinancebrief.com/story/acorn-energy-cormedix-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.